Putnam Investments LLC Atara Biotherapeutics, Inc. Transaction History

Putnam Investments LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$19.05 - $41.04 $720,280 - $1.55 Million	-37,810 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$28.4 - $41.74 $6.51 Million - $9.57 Million	-229,226 Reduced 85.84%	37,810 $1.5 Million
Q4 2018 Feb 14, 2019	SELL	$30.9 - $42.97 $26,203 - $36,438	-848 Reduced 0.32%	267,036 $9.28 Million
Q3 2018 Nov 14, 2018	SELL	$35.05 - $43.5 $994,543 - $1.23 Million	-28,375 Reduced 9.58%	267,884 $11.1 Million
Q2 2018 Aug 14, 2018	SELL	$35.15 - $51.45 $52,268 - $76,506	-1,487 Reduced 0.5%	296,259 $10.9 Million
Q1 2018 May 15, 2018	BUY	$18.0 - $48.35 $5.36 Million - $14.4 Million	297,746 New	297,746 $11.6 Million

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.15B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.